Approval · Notice of Compliance 11645 · 2010
THALOMID: Notice of Compliance 11645
Issued August 4, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11645
- Date
- August 4, 2010
- Company
- Celgene IncSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Immunomodulatory agent
Products in this notice
Medicinal ingredients
- THALIDOMIDE 50 MG per CAP
- THALIDOMIDE 100 MG per CAP
- THALIDOMIDE 150 MG per CAP
- THALIDOMIDE 200 MG per CAP